One of the main challenges in simplifying cancer treatment is the heterogeneity of cancer itself. Different types of cancer, and even different subtypes of the same cancer, may require different treatment approaches. Additionally, patients may have varying responses to treatments, and comorbid conditions can complicate simplified regimens. Personalized medicine, which tailors treatment to the individual characteristics of each patient and their disease, adds another layer of complexity.
